A nice idea for a Cushing’s educational resource

Recordati Rare Diseases, a company dedicated to creating needed therapies for extremely rare and devastating diseases, had an excellent idea of approaching their new...

Cortisol levels after Cushing’s surgery

An informal discussion of Cushing's disease issues from cases, articles, and experiences with patients.

A talk with Crinetics Chairman Scott Struthers, Ph.D.

During these trying times, work continues, even at a faster pace, for new drugs and therapies for pituitary patients. From the J D Faccinetti, co-founder...

Alternative Cushing’s syndrome treatment

Grzegorz Rosiak, M.D., an interventional radiologist from Warsaw Medical University, sends us a recently published article, "Percutaneous Adrenal Gland Thermal Ablation," an alternative Cushing syndrome...

Podcast: A conversation with Dr. Maria Fleseriu

With new advances in the Cushings space, we asked Dr. Maria Fleseriu,  Professor of Medicine and Neurological Surgery and Director of the Pituitary Center at...

More information on Recordati’s new Cushing’s drug Isturisa

In a recent press release, Recordati Rare Diseases announced the results from a Phase III study of Isturisa® (Osilodrostat) published in Lancet Diabetes and...

Doctors’ Response to June News Linking Cortisol Level to Death Risk with COVID-19

From Leslie Edwin, President of CSRF and PWN Contributor - On June 18, 2020, online medical journal The Lancet Diabetes and Endocrinology published a report...

The complex diagnosis of Cushing’s syndrome

In this engaging podcast about the diagnosis of Cushing's syndrome, Pituitary Worlds News co-founder and Medical Director, California Center for Pituitary Disorders at UCSF Professor...

From the European Society of Endocrinology: Cushing’s syndrome clinical management guidance during the...

This is a series of urgent clinical guidance documents on the management of endocrine conditions in the time of COVID-19. This clinical guidance document...

A new drug for Cushing’s: Learn more

In this podcast, Dr. Lewis Blevins discusses a new drug for Cushing's disease recently approved in the US.  

NEWS YOU CAN USE

Articles you may like